Douglas R. Palmer
Chief Financial Officer and Treasurer
Douglas Palmer has been an interim part-time Chief Financial Officer since September 2007
and currently works for Genetic Immunity, LLC. Since 2002, he has been
and currently is a principal of Palmer Financial, LLC, an accounting and finance consulting outsourcing firm,
with experience in finance operations, financial reporting and analysis, budgeting, strategic planning and accounting
system implementation. He has had recent operational experience in consulting companies in the biotechnology industry.
Specifically, at Cellective Therapeutics, a Company which focuses on B-cell research - a class of cells in the immune
system, he was involved in financial reporting, financial operations, financial and budgeting analysis. He also assisted
Cellective Therapeutics with audit and due diligence disclosure efforts in connection with it acquisition by MedImmune.
Prior to his operational experience, Mr. Palmer was an auditor and consultant for PricewaterhouseCoopers. He holds a B.S.
in Accounting from the University of Maryland and is a licensed Certified Public Accountant.